患者与医生对中重度特应性皮炎生物制剂和口服全身治疗偏好的离散选择实验

数据集获取（Figshare）

• 源站标题：Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany
• DOI：10.6084/m9.figshare.27312852.v1
• 发布日期：2024-10-28
• 文件数：4 个
• 文件总体积：3.37 MB
• 源站页面：https://tandf.figshare.com/articles/dataset/Biologics_and_oral_systemic_treatment_preferences_in_patients_and_physicians_for_moderate-to-severe_atopic_dermatitis_a_discrete_choice_experiment_in_the_United_Kingdom_and_Germany/27312852

命令行下载

curl -L -o "ijdt_a_2417966_sm8086.docx" "https://ndownloader.figshare.com/files/50024859"
curl -L -o "ijdt_a_2417966_sm8085.png" "https://ndownloader.figshare.com/files/50024862"
curl -L -o "ijdt_a_2417966_sm8084.jpg" "https://ndownloader.figshare.com/files/50024865"
curl -L -o "ijdt_a_2417966_sm8083.png" "https://ndownloader.figshare.com/files/50024868"

文件清单

• ijdt_a_2417966_sm8086.docx（112.63 KB）
• ijdt_a_2417966_sm8085.png（664.50 KB）
• ijdt_a_2417966_sm8084.jpg（1.93 MB）
• ijdt_a_2417966_sm8083.png（663.02 KB）

文件总体积 3.37 MB（源站 API 实测）。

数据说明

Background: As the available treatments for moderate-to-severe atopic dermatitis (AD) expand, understanding patient and physician preferences becomes crucial for informed decision-making.
Objective: To quantify patient and physician preferences for biologics and oral systemic AD treatment attributes.
Materials and methods: We conducted a cross-sectional, online discrete choice experiment (DCE) involving 306 AD patients and 206 physicians throughout the United Kingdom and Germany. Qualitative interviews identified the key attributes for inclusion in the DCE. Each choice task comprised two hypothetical patient profiles. Data were analyzed using a random-parameters logit model.
Results: Results indicated a significant emphasis on efficacy, with reducing sleep disturbance and itch ranking first and second among patients, and the reverse for physicians. Time to itch relief was the third most important efficacy attribute for both groups, but relatively more important for patients than for physicians. For both groups, the risk of eye problems was the most important safety concern of those included. Mode of administration was not of great importance compared to efficacy and safety attributes.
Conclusions: Our findings suggest patients prioritize sleep disturbance, an attribute not captured in prior preference studies in AD, time to itch relief and itch. These findings emphasize the importance of addressing sleep-related issues, whilst also targeting fast itch control, to enhance patients’ well-being.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.27312852.v1（source: https://tandf.figshare.com/articles/dataset/Biologics_and_oral_systemic_treatment_preferences_in_patients_and_physicians_for_moderate-to-severe_atopic_dermatitis_a_discrete_choice_experiment_in_the_United_Kingdom_and_Germany/27312852）。